awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q46574374-0E6C5F28-02C4-49BC-945A-0DA982E7FA25
Q46574374-0E6C5F28-02C4-49BC-945A-0DA982E7FA25
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46574374-0E6C5F28-02C4-49BC-945A-0DA982E7FA25
A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma.
P2860
Q46574374-0E6C5F28-02C4-49BC-945A-0DA982E7FA25
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46574374-0E6C5F28-02C4-49BC-945A-0DA982E7FA25
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c50782c93d587c499c984618be57c30773601157
P2860
A potential use of a synthetic retinoid TAC-101 as an orally active agent that blocks angiogenesis in liver metastases of human stomach cancer cells.